Vascular KCNQ channels in humans: The sub-threshold brake that regulates vascular tone?

British Journal of Pharmacology

Volumn 162, Issue 1, 2011, Pages 38-41

  Mani, Bharath K ^a   Byron, Kenneth L ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

human artery; KCNQ; potassium channel; vasoconstriction; vasodilation

Indexed keywords

ACRYLAMIDE; CALCIUM ION; CELECOXIB; CHROMANOL 293B; CYCLOOXYGENASE 2 INHIBITOR; FLUPIRTINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; POTASSIUM CHANNEL KCNQ4; POTASSIUM CHANNEL KCNQ5; RETIGABINE; VASOPRESSIN;

ARTERY CONSTRICTION; ARTERY DILATATION; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL TONE; CALCIUM CURRENT; CARDIOVASCULAR DISEASE; CHANNEL GATING; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER MEMBRANE POTENTIAL;

ANIMALS; BLOOD VESSELS; HUMANS; KCNQ POTASSIUM CHANNELS; MICE; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; RATS;

EID: 78650126147     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01065.x     Document Type: Review

References (14)

1. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
2. Brown DA, (2008). Kv7 (KCNQ) potassium channels that are mutated in human diseases. J Physiol 586: 1781-1783.
3. Brueggemann LI, Mackie AR, Mani BK, Cribbs LL, Byron KL, (2009). Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles. Mol Pharmacol 76: 1053-1061.
4. Chambard JM, Ashmore JF, (2005). Regulation of the voltage-gated potassium channel KCNQ4 in the auditory pathway. Pflugers Arch 450: 34-44.
5. Dalby-Brown W, Hansen HH, Korsgaard MP, Mirza N, Olesen SP, (2006). K(v)7 channels: function, pharmacology and channel modulators. Curr Top Med Chem 6: 999-1023.
6. Delmas P, Brown DA, (2005). Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 6: 850-862.
7. Herrmann WM, Kern U, Aigner M, (1987). On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an ongoing twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis. Postgrad Med J 63 (Suppl. 3): 87-103.
8. Jentsch TJ, (2000). Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci 1: 21-30.
9. Joshi S, Sedivy V, Hodyc D, Herget J, Gurney AM, (2009). KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle. J Pharmacol Exp Ther 329: 368-376.
10. Mackie AR, Brueggemann LI, Henderson KK, Shiels AJ, Cribbs LL, Scrogin KE, et al. (2008). Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction: based on studies in single cells, pressurized arteries and in vivo measurements of mesenteric vascular resistance. J Pharmacol Exp Ther 325: 475-483.
11. + channel KCNQ genes in human arteries. Br J Pharmacol 162: 42-53.
12. (Ks) potassium channel. Nature 384: 80-83.
13. Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, et al. (1998). KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282: 1890-1893.
14. Yeung SY, Pucovsky V, Moffatt JD, Saldanha L, Schwake M, Ohya S, et al. (2007). Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity. Br J Pharmacol 151: 758-770.